Rohit Jain, MD, MPH
Rohit K. Jain MD, MPH is an Associate Professor of Medicine at Weill Cornell Medicine and Attending Physician at NewYork-Presbyterian Hospital- Weill Cornell Medical Center. Dr. Jain earned his medical degree at Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, India. He completed Internal Medicine Residency at Johns Hopkins University/Sinai Hospital of Baltimore and Hematology-Oncology Fellowship at Roswell Park Cancer Institute University at Buffalo, New York. After fellowship, Dr. Jain, joined the H. Lee Moffitt Cancer Center in Tampa, Florida as Assistant Professor, and was instrumental in building the bladder cancer program. Dr. Jain was selected as Castle Connolly “Top Doctor” for 2024, as well as one of America’s Best Prostate Cancer Oncologist by Newsweek magazine in 2024. Dr. Jain was recruited to Weill Cornell Medicine (WCM) in 2024. He cares for patients with bladder (urothelial), kidney (renal), prostate and testicular cancers, with a major focus in urothelial cancers. His research interests are primarily in urothelial and prostate cancers. Dr. Jain is involved in biomarker research as well as developing innovative clinical trials for patients, and he has received funding from the National Cancer Institute (NCI).
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Johnson and JohnsonDate added:02/27/2025Date updated:02/27/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Eli-LillyDate added:02/27/2025Date updated:02/27/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Axiom Healthcare StrategiesDate added:02/27/2025Date updated:02/27/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:BMSDate added:02/27/2025Date updated:02/27/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BMSDate added:02/27/2025Date updated:02/27/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:GileadDate added:02/27/2025Date updated:02/27/2025